Ark Solutions Inc. logo

Ark Solutions Inc. (203690)

Market Closed
8 Jul, 06:30
KRX SM KRX SM
139. 00
0
0%
76.18B Market Cap
- P/E Ratio
- Div Yield
4.1M Volume
- Eps
139
Previous Close
Add Transaction
Day Range
139 139
Year Range
76 4,580
Want to track 203690 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

203690 closed Wednesday higher at ₩139, an increase of 0% from Tuesday's close, completing a monthly increase of 33.6538% or ₩35. Over the past 12 months, 203690 stock lost -96.8588%.
203690 is not paying dividends to its shareholders.
Ark Solutions Inc. has completed 2 stock splits, with the recent split occurring on May 12, 2023.
The company's stock is traded on one exchange.

203690 Chart

People also search for

Fine M-Tec Co., Ltd.
8,930
-2.5109%
Genexine Co., Ltd.
2,755
+1.2868%
TiumBio Co., Ltd.
4,950
-1.5905%
GeneOne Life Science Inc.
2,670
0%
Iljin Diamond Co. Ltd.
9,160
0%

Ark Solutions Inc. (203690) FAQ

What is the stock price today?

The current price is ₩139.00.

On which exchange is it traded?

Ark Solutions Inc. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 203690.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 76.18B.

Has Ark Solutions Inc. ever had a stock split?

Ark Solutions Inc. had 2 splits and the recent split was on May 12, 2023.

Ark Solutions Inc. Profile

Biotechnology Industry
Healthcare Sector
Mr. Yoon-Ho Oh CEO
KRX SM Exchange
- ISIN
South Korea Country
54 Employees
- Last Dividend
14 Apr 2023 Last Split
- IPO Date

Overview

Sphere Power Inc., originally known as Prostemics Co., Ltd. before renaming in July 2023, has made its mark by engaging in the research and development of innovative products utilizing protein. Founded in 2005 and based in Seoul, South Korea, the company has expanded its reach to Japan, Mexico, and other international markets. Sphere Power Inc. operates through two main divisions: the Life and Health Business and the Exosome Business division, focusing on leveraging stem cell technology. Beyond its core research areas, Sphere Power Inc. has also ventured into the production of sanitary paper products, showcasing its diverse interests and capabilities in the health and wellness sector.

Products and Services

AAPE

This product line offers a high concentration of human cell culture medium designed to enhance the skin and scalp's health. Targeted at hospitals and clinics, AAPE leverages advanced biotechnology to promote skin rejuvenation and vitality, standing out as a premier solution for dermatological care.

Cytovesicle

Cytovesicle is a cutting-edge product incorporating cytocore and a high concentration of human stem cell culture medium. It is engineered to restore and promote a healthy microbial ecosystem for both the skin and scalp. Through fostering a balanced microbial environment, Cytovesicle aims to improve overall dermatological health and resilience.

CellExocome

Featuring plant nanovesicle technology alongside soluble protein and a high concentration of human stem cell culture medium, CellExocome is designed to maintain healthy skin and scalp conditions. Its innovative formulation supports the skin's natural barrier and promotes a vibrant, healthy appearance making it a valuable addition to Sphere Power Inc.'s cosmetic offerings for healthcare providers.

In addition to its advanced dermatology products, Sphere Power Inc. diversifies its portfolio by manufacturing sanitary paper products. This expansion into daily health and hygiene items demonstrates the company's broad approach to improving human health and wellness.

Contact Information

Address: Room 309, 58, Wangsimni-ro
Phone: 82 2 2284 0220